CompletedPhase 3NCT00363584
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer
Studying Rare tumor of liver and intrahepatic biliary tract
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Principal Investigator
- Clive StubbsCancer Research Campaign Clinical Trials Centre
- Intervention
- capecitabine(drug)
- Enrollment
- 360 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2006
Study locations (30)
- Basildon University Hospital, Basildon, England, United Kingdom
- Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, England, United Kingdom
- Cancer Research UK Clinical Trials Unit - Birmingham, Birmingham, England, United Kingdom
- Royal Bournemouth Hospital, Bournemouth, England, United Kingdom
- Bristol Haematology and Oncology Centre, Bristol, England, United Kingdom
- Addenbrooke's Hospital, Cambridge, England, United Kingdom
- Walsgrave Hospital, Coventry, England, United Kingdom
- Princess Alexandra Hospital, Essex, England, United Kingdom
- St. Luke's Cancer Centre at Royal Surrey County Hospital, Guildford, England, United Kingdom
- Calderdale Royal Hospital, Halifax, England, United Kingdom
- Huddersfield Royal Infirmary, Huddersfield, West Yorks, England, United Kingdom
- Cancer Research UK Clinical Centre at St. James's University Hospital, Leeds, England, United Kingdom
- Leicester Royal Infirmary, Leicester, England, United Kingdom
- Leicester General Hospital, Leicester, England, United Kingdom
- Royal Liverpool University Hospital, Liverpool, England, United Kingdom
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00363584 on ClinicalTrials.govOther trials for Rare tumor of liver and intrahepatic biliary tract
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07356531Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver CancerJIANGSU SHENMING Medical Technology CO., Ltd
- ACTIVE NOT RECRUITINGNCT04145141National Translational Science Network of Precision-based Immunotherapy for Primary Liver CancerNational Cancer Institute (NCI)
- ACTIVE NOT RECRUITINGNANCT02984566Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)University of Sydney
See all trials for Rare tumor of liver and intrahepatic biliary tract →